Mast cells distribution in human liver disease and experimental rat liver fibrosis. Indications for mast cell participation in development of liver fibrosis

Journal of Hepatology

Volumn 26, Issue 5, 1997, Pages 1042-1054

  Armbrust, Thomas ^a   Batusic, Danko ^a   Ringe, Burkhardt ^b   Ramadori, Giuliano ^a  

^a Innere Medizin   (Germany)

^b Abt Transplantationschirurgie G   (Germany)

Author keywords

Cirrhosis; Liver disease; Mast cells

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR DISTRIBUTION; CHRONIC LIVER DISEASE; FEMALE; FIBROGENESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; LIVER FIBROSIS; MAST CELL; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; RAT;

EID: 0030967254     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80113-4     Document Type: Article

References (57)

1. Hartroft WS, Ridout JH. Pathogenesis of the cirrhosis produced by choline deficiency. Escape of lipid from fatty hepatic cysts into the biliary and vascular system. Am J Pathol. 27:1951;951-989.
2. Knittel T, Schuppan D, Meyer zum Büschenfelde KH, Ramadori G. Differential expression of collagen types I, III, and IV by fat-storing (Ito) cells in vitro. Gastroenterology. 102:1992;1724-1735.
3. Ramadori G. The stellate cell (Ito-cell, fat-storing cell, lipocyte, perisinusoidal cell) of the liver. Virchows Arch B Cell pathol. 61:1991;147-158.
4. Knittel T, Ramadori G. Current concepts of the liver fibrosis. Trends Exp Clin Med. 4:1994;236-257.
5. Fallerell DJ, Hines JE, Walls AF, Kelly PJ, Bennett MK, Burt AD. Intrahepatic mast cells in chronic liver disease. Hepatology. 22:1995;1175-1181.
6. Schwartz LB. Mast cells: function and contents. Curr Opin Immunol. 6:1994;91-97.
7. Galli SJ. New concepts about the mast cell. Engl J Med. 328:1993;257-265.
8. Fodinger M, Fritsch G, Winkler K, Emminger W, Mitterbauer G, Gadner H, Valent P, et al. Origin of human mast cells: development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation. Blood. 84:1994;2954-2959.
9. Kitamura Y. Heterogeneity of mast cells and phenotypic changes between subpopulations. Ann Rev Immunol. 7:1989;59-76.
10. Galli SJ. New insights into "the riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest. 62:1990;5-33.
11. Schwartz LB. Tryptase from human mast cells: biochemistry, biology and clinical utility. Schwartz LB. Neutral Proteases of Mast Cells. 27:1990;90-113 Karger, Basel, Munich, Paris, London, New York.
12. Schechter NM. Human chymase. Schwartz LB. Neutral Proteases of Mast Cells. 27:1990;114-131 Karger, Basel, Munich, Paris, London, New York.
13. + cells. Adv Immunol. 53:1993;1-29.
14. Leal-Berumen I, Conlon P, Marshall JS. IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J Immunol. 152:1994;5468-5476.
15. Oh CK, Metcalfe DD. Transcriptional regulation of the TCA3 gene in mast cells after Fc epsilon RI cross-linking. J Immunol. 153:1994;325-32.
16. Gordon JR, Galli SJ. Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/ cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanical for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological response. J Exp Med. 174:1991;103-107.
17. Alam R, Kumar D, Anderson WD, Forsythe PA. Macrophage inflammatory protein-1 alpha and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. J Immunol. 152:1994;1298-1303.
18. Smith TJ, Ducharme LA, Weis JH. Preferential expression of interleukin-12 or interleukin-4 by murine bone marrow mast cells derived in mast cell growth factor or interleukin-3. Eur J Immunol. 24:1994;822-826.
19. Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol Today. 11:1990;458-464.
20. Galli SJ, Gordon JR, Wershil BK. Cytokine production by mast cells and basophils. Curr Opin Immunol. 3:1991;865-872.
21. Valent P. The phenotype of human eosinophils, basophils, and mast cells. J Allergy Clin Immunol. 94:1994;1177-1183.
22. Martin FH, Suggs SV, Langley KE, Lu HS, Ting J, Okino KH, Morris CF, et al. Primary structure and functional expression of rat and human stem cell factor DNAs. Cell. 63:1990;203-211.
23. Lemura A, Tsai M, Ando A, Wershil BK, Galli SJ. The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol. 144:1994;321-328.
24. Tenascin gene expression in rat liver and in rat liver cells Ramadori G, Schwögler S, Veit T, Rieder H, Chiquet-Ehrismann R, Mackie EJ, Meyer zum Büschenfelde K-H. In vivo and in vitro studies. Virchows Arch B Cell Pathol. 60:1991;145-153.
25. Proctor E, Chatamra K. High yield micronodular cirrhosis in the rat. Gastroenterology. 83:1982;1183-1190.
26. 4-induced acute damage or fibrosis. Biochim Biophys Acta. 1181:1993;266-272.
27. Yurt RW, Leid RW, Austen KF. Native heparin from rat peritoneal mast cells. J Biol Chem. 252:1977;518-521.
28. Enerbäck L. Mast cells in rat gastrointestinal mucosa. 2. Dye-binding and metachromatic properties. APMIS. 66:1966;289-322.
29. Blaies DM, Williams JF. A simplified method for staining mast cells with astra blue. Stain Tech. 56:1981;91-94.
30. Strobel S, Miller HRP, Ferguson A. Human intestinal mucosal mast cells: evaluation of fixation and staining techniques. J Clin Pathol. 34:1981;851-857.
31. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KAF, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP) complexes. J Histochem Cytochem. 32:1984;219-229.
32. Naidoo N, Cooperman BS, Wang ZM, Liu XZ, Rubin H. Identification of lysines within alpha 1-antichymotrypsin important for DNA binding. An unusual combination of DNA-binding elements. J Biol Chem. 270:1995;14548-14555.
33. Chanez P, Lacoste JY, Guillot B, Giron J, Barneon G, Enander I, Godard P, et al. Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung. Am Rev Respir Dis. 147:1993;1497-1502.
34. Claman HN. Mast cells, T cells and abnormal fibrosis. Immunol Today. 6:1985;192-195.
35. Claman HN. On scleroderma. Mast cells, endothelial cells, and fibroblasts. JAMA. 262:1989;1206-1209.
36. Frieri M. Systemic sclerosis. The role of the mast cell and cytokines. Ann Allergy. 69:1992;385-396.
37. Atkins FM, Clark RAF. Mast cells and fibrosis. Arch Dermatol. 123:1987;191-193.
38. Pesci A, Bertorelli G, Gabrielli M, Olivieri D. Mast cells in fibrotic lung disorders. Chest. 103:1993;989-996.
39. Sawers AW, Davson J, Braganza J, Geary CG. Systemic mastocytosis, myelofibrosis and portal hypertension. J Clin Pathol. 35:1982;617-619.
40. Gruber BL, Marchese MJ, Kew RR. Transforming growth factor-β1 mediates must cell chemotaxis. J Immuno. 152:1994;5860-5867.
41. Mekori YA, Metcalfe DD. Transforming growth factor-β prevents stem cell factor-mediated rescue of mast cells from apoptosis after IL-3 deprivation. J Immunol. 153:1994;2194-2203.
42. Gordon JR, Galli SJ. Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc epsilon RI. Role for mast cell-derived transforming growth factor beta and tumor necrosis factor alpha. J Exp Med. 180:1994;2027-2037.
43. Dvorak AM, Mitsui H, Ishizaka T. Stimulation of partial development of human must cells by supernatant fluid from mouse fibroblast cultures. Clin Exp Allergy. 24:1994;649-659.
44. Galli SJ, Zsebo KM, Geissler EN. The c-kit ligand, stem cell factor. Adv Immunol. 55:1994;1-96.
45. Potempa J, Korzus E, Travis J. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J. Biol Chem. 269:1994;15957-15960.
46. Ramadori G, Knittel T, Schwögler S, Bieber F, Rieder H, Meyer zum Büschenfelde KH. Dexamethasone modulates alpha 2-macroglobulin and apolipoprotein E gene expression in cultured rat liver fat-storing (Ito) cells. Hepatology. 14:1991;875-882.
47. Schwögler S, Odenthal M, Knittel T, Meyer zum Büschenfelde KH, Ramadori G. Fat-storing cells of the rat liver synthesize and secrete C1-esterase inhibitor; modulation by cytokines. Hepatology. 16:1992;794-802.
48. Iredale JP, Murphy G, Hembry RM, Friedman SL, Arthur MJ. Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver. J Clin Invest. 90:1992;282-287.
49. Beatty K, Bieth J, Travis J. Kinetics of association of serine proteinase with native and oxidized alpha 1-proteinase inhibitor and alpha 1-antichymotrypsin. J Biol Chem. 255:1980;3931-3934.
50. Hook VYH, Purviance RT, Azaryan AV, Hubbard G, Krieger TJ. Purification and characterization of alpha 1-antichymotrypsin-like protease inhibitor that regulates prohormone thiol protease involved in enkephalin precursor processing. J Biol Chem. 268:1993;20570-20577.
51. Travis J, Salvesen GS. Human plasma proteinase inhibitors. Annu Rev Biochem. 52:1983;655-709.
52. Briggaman RA, Schechter NM, Fraki J, Lazarus GS. Degradation of the epidermal-dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes. J Exp Med. 160:1984;1027-1042.
53. Sage H, Woodbury RG, Bornstein P. Structural studies on human type IV collagen. J Biol Chem. 254:1979;9893-9900.
54. Gailit J, Clark RAF. Wound repair in the context of extra-cellular matrix. Curr Opin Cell Biol. 6:1994;717-725.
55. Neubauer K, Knittel T, Armbrust T, Ramadori G. Accumulation and cellular localization of fibrinogen/fibrin during short-term and long-term rat liver injury. Gastroenterology. 108:1995;1124-1135.
56. Armbrust T, Ramadori G. Functional characterization of two different Kupffer cell populations of normal rat liver. J Hepatol. 25:1996;518-528.
57. Armbrust T, Ramadori G. Mononuclear phagocytes of acutely injured rat liver abundantly synthesize and secrete fibronectin in contrast to Kupffer cells of normal rat liver. Biochem Biophys Res Commun. 213:1995;752-758.